China added three TCM formula to COVID-19 standard therapy
The Chinese government had officially recognised three TCM formulas as part of its standard therapy for COVID-19.
The three formulas – Lianhua Qingwen Capsule, Jinhua Qinggan Granule, and Xuebijing Injection – were patented products that are already commercially available and have been tested on COVID-19 patients in clinical settings.
The first two were herbal products featuring ingredients such as honeysuckle and weet wormwood.
They were now recognised as part of China’s Standard Therapy for Novel Coronavirus Pneumonia (Tentative, version VII), the National Administration of Traditional Chinese Medicine announced last Wed (Apr 15).